Sensorimotor Exercises and Neurodevelopmental Yoga in Chronic Neck Pain
Launched by MEDIPOL UNIVERSITY · Jan 24, 2024
Trial Information
Current as of June 22, 2025
Completed
Keywords
ClinConnect Summary
Participants diagnosed with chronic neck pain will be randomly divided into two groups as sensorimotor exercise group and yoga group by the evaluator. Sensorimotor exercise group; oculomotor exercise to provide information from the visual system, laser target exercise to provide information from the proprioception system, and postural stability exercise to provide information from the vestibular system. Yoga group will be given yoga exercises. Within the content of oculomotor exercise, gaze stability exercise and head-body coordination exercise will be given to the participants. Laser targe...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • aged 24-60 years of either sex, at least a 12 weeks history of CNP, CNP according to the Quebec Task Force grading system in Grade 1 and 2
- Exclusion Criteria:
- • according to Quebec Task Force grading system Grade 3 and 4 neck pain, neurological defects, speech and perception disorders, psychiatric diagnosis, recent history of neck trauma, recent history of cancer, diagnosed vestibular disorder, participants who diagnosed eye disorders, recent history of surgery, contraindications to yoga.
About Medipol University
Medipol University is a leading academic institution dedicated to advancing medical research and clinical innovation. With a strong emphasis on interdisciplinary collaboration, the university conducts rigorous clinical trials aimed at improving patient outcomes and enhancing healthcare practices. Leveraging state-of-the-art facilities and a team of experienced researchers and healthcare professionals, Medipol University is committed to contributing to the global medical community through ethical research and the development of novel therapeutic strategies. The institution fosters an environment of academic excellence and integrity, ensuring that all trials adhere to the highest standards of safety and efficacy.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, Beykoz, Turkey
Patients applied
Trial Officials
Dilanur Kutlu Özkaraoğlu, MsC
Principal Investigator
Istanbul MedipolUniversity
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported